EMA has set up a new advisory group on vaccine confidence, which will advise the Agency on issues related to vaccine hesitancy and help guide its actions to increase science outreach in this area. This panel, made up of over 20 high-level European and international experts, meets for the first time on 29 April.

The main objectives of the advisory group are to:

• advise on and contribute to the environmental analysis related to the status of vaccine hesitancy 

• advise on EMA’s ongoing initiatives to increase vaccine confidence 

• contribute to improving EMA’s communication to the public on the benefits and risks of vaccines

• help amplify the Agency’s science outreach and public health messages

Actions include identifying and addressing public concerns that may affect confidence, collaborating with healthcare professionals and public health initiatives, as well as developing communication materials and campaigns on vaccines.